205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
11.15%
Revenue growth 1.25-1.5x MCHP's 9.46%. Bruce Berkowitz would examine if growth advantage is sustainable.
10.63%
Cost growth 1.25-1.5x MCHP's 7.88%. Martin Whitman would scrutinize competitive cost position.
8.67%
Similar gross profit growth to MCHP's 10.95%. Walter Schloss would investigate industry dynamics.
-2.23%
Margin decline while MCHP shows 1.36% expansion. Joel Greenblatt would examine competitive position.
33.25%
R&D growth above 1.5x MCHP's 13.88%. Michael Burry would check for spending discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Other expenses reduction while MCHP shows 0.00% growth. Joel Greenblatt would examine efficiency.
23.10%
Operating expenses growth above 1.5x MCHP's 6.51%. Michael Burry would check for inefficiency.
14.69%
Total costs growth above 1.5x MCHP's 7.41%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
57.87%
D&A growth above 1.5x MCHP's 5.82%. Michael Burry would check for excessive investment.
95.13%
EBITDA growth exceeding 1.5x MCHP's 12.06%. David Dodd would verify competitive advantages.
95.61%
EBITDA margin growth exceeding 1.5x MCHP's 2.37%. David Dodd would verify competitive advantages.
-14.93%
Operating income decline while MCHP shows 15.20% growth. Joel Greenblatt would examine position.
-23.46%
Operating margin decline while MCHP shows 5.24% growth. Joel Greenblatt would examine position.
-58.67%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-45.31%
Pre-tax income decline while MCHP shows 14.51% growth. Joel Greenblatt would examine position.
-50.79%
Pre-tax margin decline while MCHP shows 4.61% growth. Joel Greenblatt would examine position.
-40.36%
Tax expense reduction while MCHP shows 14.52% growth. Joel Greenblatt would examine advantage.
-47.61%
Net income decline while MCHP shows 14.51% growth. Joel Greenblatt would examine position.
-52.86%
Net margin decline while MCHP shows 4.61% growth. Joel Greenblatt would examine position.
-48.68%
EPS decline while MCHP shows 16.64% growth. Joel Greenblatt would examine position.
-47.22%
Diluted EPS decline while MCHP shows 12.15% growth. Joel Greenblatt would examine position.
0.47%
Share count increase while MCHP reduces shares. John Neff would investigate differences.
-4.07%
Diluted share reduction while MCHP shows 0.62% change. Joel Greenblatt would examine strategy.